Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 22, 2022 - Issue 6
Submit an article Journal homepage
675
Views
3
CrossRef citations to date
0
Altmetric
Review

Emerging therapies for human hearing loss

Elise Ajaya Bionics Institute, East Melbourne, Victoria, Australia;b Department of Engineering, University of Melbourne, AustraliaView further author information
,
Niliksha Gunewardenea Bionics Institute, East Melbourne, Victoria, AustraliaORCID Iconhttps://orcid.org/0000-0003-4836-1318View further author information
ORCID Icon &
Rachael Richardsona Bionics Institute, East Melbourne, Victoria, Australia;c Medical Bionics Department, University of Melbourne, Parkville, Victoria, Australia;d Department of Surgery (Otolaryngology), University of Melbourne, East Melbourne, Victoria, AustraliaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2412-8354View further author information
ORCID Icon
Pages 689-705 | Received 10 Jan 2022, Accepted 27 Apr 2022, Published online: 11 May 2022

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Colleen G. Le Prell. (2023) Preclinical prospects of investigational agents for hearing loss treatment. Expert Opinion on Investigational Drugs 32:8, pages 685-692.
Read now

Articles from other publishers (2)

Xiangyu Ma, Jiamin Guo, Yaoyang Fu, Cangsong Shen, Pei Jiang, Yuan Zhang, Lei Zhang, Yafeng Yu, Jiangang Fan & Renjie Chai. (2022) G protein-coupled receptors in cochlea: Potential therapeutic targets for hearing loss. Frontiers in Molecular Neuroscience 15.
Crossref
Irina Marcovich, Nicholas K. Baer, Olga Shubina-Oleinik, Rachel Eclov, Clayton W. Beard & Jeffrey R. Holt. (2022) Optimized AAV Vectors for TMC1 Gene Therapy in a Humanized Mouse Model of DFNB7/11. Biomolecules 12:7, pages 914.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.